196 related articles for article (PubMed ID: 24858839)
1. Coadministration of co-trimoxazole with sulfonylureas: hypoglycemia events and pattern of use.
Tan A; Holmes HM; Kuo YF; Raji MA; Goodwin JS
J Gerontol A Biol Sci Med Sci; 2015 Feb; 70(2):247-54. PubMed ID: 24858839
[TBL] [Abstract][Full Text] [Related]
2. Hypoglycemia after antimicrobial drug prescription for older patients using sulfonylureas.
Parekh TM; Raji M; Lin YL; Tan A; Kuo YF; Goodwin JS
JAMA Intern Med; 2014 Oct; 174(10):1605-12. PubMed ID: 25179404
[TBL] [Abstract][Full Text] [Related]
3. Anti-infectives and the risk of severe hypoglycemia in users of glipizide or glyburide.
Schelleman H; Bilker WB; Brensinger CM; Wan F; Hennessy S
Clin Pharmacol Ther; 2010 Aug; 88(2):214-22. PubMed ID: 20592722
[TBL] [Abstract][Full Text] [Related]
4. Association between use of warfarin with common sulfonylureas and serious hypoglycemic events: retrospective cohort analysis.
Romley JA; Gong C; Jena AB; Goldman DP; Williams B; Peters A
BMJ; 2015 Dec; 351():h6223. PubMed ID: 26643108
[TBL] [Abstract][Full Text] [Related]
5. A prospective trial of risk factors for sulfonylurea-induced hypoglycemia in type 2 diabetes mellitus.
Burge MR; Schmitz-Fiorentino K; Fischette C; Qualls CR; Schade DS
JAMA; 1998 Jan; 279(2):137-43. PubMed ID: 9440664
[TBL] [Abstract][Full Text] [Related]
6. Hypoglycemia in hospitalized patients treated with sulfonylureas.
Deusenberry CM; Coley KC; Korytkowski MT; Donihi AC
Pharmacotherapy; 2012 Jul; 32(7):613-7. PubMed ID: 22570146
[TBL] [Abstract][Full Text] [Related]
7. Sentinel Modular Program for Propensity Score-Matched Cohort Analyses: Application to Glyburide, Glipizide, and Serious Hypoglycemia.
Zhou M; Wang SV; Leonard CE; Gagne JJ; Fuller C; Hampp C; Archdeacon P; Toh S; Iyer A; Woodworth TS; Cavagnaro E; Panozzo CA; Axtman S; Carnahan RM; Chrischilles EA; Hennessy S
Epidemiology; 2017 Nov; 28(6):838-846. PubMed ID: 28682851
[TBL] [Abstract][Full Text] [Related]
8. Glycemic control and hypoglycemia in Veterans Health Administration patients converted from glyburide to glipizide.
Skoff RA; Waterbury NV; Shaw RF; Egge JA; Cantrell M
J Manag Care Pharm; 2011 Nov; 17(9):664-71. PubMed ID: 22050391
[TBL] [Abstract][Full Text] [Related]
9. Individual sulfonylureas and serious hypoglycemia in older people.
Shorr RI; Ray WA; Daugherty JR; Griffin MR
J Am Geriatr Soc; 1996 Jul; 44(7):751-5. PubMed ID: 8675920
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-Converting Enzyme Inhibitors Used Concomitantly with Insulin Secretagogues and the Risk of Serious Hypoglycemia.
Hee Nam Y; Brensinger CM; Bilker WB; Flory JH; Leonard CE; Hennessy S
Clin Pharmacol Ther; 2022 Jan; 111(1):218-226. PubMed ID: 34312836
[TBL] [Abstract][Full Text] [Related]
11. Comparative safety of sulfonylureas among U.S. nursing home residents.
Zullo AR; Riester MR; Hayes KN; Munshi MN; Berry SD
J Am Geriatr Soc; 2023 Apr; 71(4):1047-1057. PubMed ID: 36495141
[TBL] [Abstract][Full Text] [Related]
12. Deintensification of Treatment With Sulfonylurea and Insulin After Severe Hypoglycemia Among Older Adults With Diabetes.
Alexopoulos AS; Kahkoska AR; Pate V; Bradley MC; Niznik J; Thorpe C; Stürmer T; Buse J
JAMA Netw Open; 2021 Nov; 4(11):e2132215. PubMed ID: 34726745
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic Differences of Sulfonylureas and the Risk of Adverse Cardiovascular and Hypoglycemic Events.
Douros A; Yin H; Yu OHY; Filion KB; Azoulay L; Suissa S
Diabetes Care; 2017 Nov; 40(11):1506-1513. PubMed ID: 28864502
[TBL] [Abstract][Full Text] [Related]
14. Comparative Safety of Sulfonylureas and the Risk of Sudden Cardiac Arrest and Ventricular Arrhythmia.
Leonard CE; Brensinger CM; Aquilante CL; Bilker WB; Boudreau DM; Deo R; Flory JH; Gagne JJ; Mangaali MJ; Hennessy S
Diabetes Care; 2018 Apr; 41(4):713-722. PubMed ID: 29437823
[TBL] [Abstract][Full Text] [Related]
15. Severe hypoglycemia in users of sulfonylurea antidiabetic agents and antihyperlipidemics.
Leonard CE; Bilker WB; Brensinger CM; Han X; Flory JH; Flockhart DA; Gagne JJ; Cardillo S; Hennessy S
Clin Pharmacol Ther; 2016 May; 99(5):538-47. PubMed ID: 26566262
[TBL] [Abstract][Full Text] [Related]
16. Symptomatic hypoglycemia secondary to a glipizide-trimethoprim/sulfamethoxazole drug interaction.
Johnson JF; Dobmeier ME
DICP; 1990 Mar; 24(3):250-1. PubMed ID: 2316232
[TBL] [Abstract][Full Text] [Related]
17. Persistent and severe hypoglycemia associated with trimethoprim-sulfamethoxazole in a frail diabetic man on polypharmacy: A case report and literature review
.
Rossio R; Arcudi S; Peyvandi F; Piconi S
Int J Clin Pharmacol Ther; 2018 Feb; 56(2):86-89. PubMed ID: 29191263
[TBL] [Abstract][Full Text] [Related]
18. Glyburide-ciprofloxacin interaction with resistant hypoglycemia.
Roberge RJ; Kaplan R; Frank R; Fore C
Ann Emerg Med; 2000 Aug; 36(2):160-163. PubMed ID: 10918110
[TBL] [Abstract][Full Text] [Related]
19. The Hypoglycemic Risk of Glyburide (Glibenclamide) Compared with Modified-Release Gliclazide.
Clemens KK; McArthur E; Dixon SN; Fleet JL; Hramiak I; Garg AX
Can J Diabetes; 2015 Aug; 39(4):308-16. PubMed ID: 25840942
[TBL] [Abstract][Full Text] [Related]
20. Drug-drug interactions among elderly patients hospitalized for drug toxicity.
Juurlink DN; Mamdani M; Kopp A; Laupacis A; Redelmeier DA
JAMA; 2003 Apr; 289(13):1652-8. PubMed ID: 12672733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
